Records containing: Wilson Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-10-27A Phase 2, Open-label Study to Assess Copper and Molybdenum Balance in Participants With Wilson Disease Treated With ALXN1840
-
CLINICAL_TRIALS study record update · 2023-10-10A Phase 3, Randomized, Rater-Blinded, Multi-Center Study to Evaluate the Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older, With an Extension Period of up to 60 Months
-
CLINICAL_TRIALS study record update · 2023-08-31A Phase 1, Randomized, 2-Period, 2-Sequence, Cross-over Study to Determine the Effect of ALXN1840 on the Metabolism of a CYP2B6 Substrate in Healthy Participants
-
CLINICAL_TRIALS study record update · 2023-08-21A Phase 1, Randomized, 2-Period, 2-Sequence, Cross-over Study to Determine the Effect of ALXN1840 on the Metabolism of a CYP2C9 Substrate in Healthy Participants.
-
CLINICAL_TRIALS study record update · 2023-07-03A Phase 2, Single-arm Pathologist-blinded 48-week Study Using Liver Biopsy Specimens to Assess Copper Concentration and Histopathologic Changes in ALXN1840-treated Patients With Wilson Disease Followed by an up to 48-weeks Extension Period
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-06-12Observational Clinical Study of Anti-AAV Seroprevalence in Subjects With Ornithine Transcarbamylase Deficiency, Glycogen Storage Disorder Type Ia, and Wilson Disease
-
CLINICAL_TRIALS study record update · 2023-05-17Early Access Program for ALXN1840 in Patients With Wilson Disease
-
CLINICAL_TRIALS study record update · 2023-04-20CHELATE STUDY: Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease
-
CLINICAL_TRIALS study record update · 2022-04-29Clinical Evaluation and Assessment of Instruments and Biomarkers in Subjects With Wilson Disease
-
CLINICAL_TRIALS study record update · 2022-03-03Study of Retinal Vascular Parameters in Patients With Wilson's Disease
-
CLINICAL_TRIALS study record update · 2021-09-29A Phase 2, Multi-centre, Open-label, Study to Evaluate the Efficacy and Safety of WTX101 Administered for 24 Weeks in Newly Diagnosed Wilson Disease Patients Aged 18 and Older With an Extension Phase of 36 Months
-
CLINICAL_TRIALS study record update · 2021-07-16Role for Biochemical Assays and Kayser-Fleischer Rings in Diagnosis of Wilson Disease
-
CLINICAL_TRIALS study record update · 2021-07-16Clinical Features and Outcome of Wilson's Disease With Generalized Epilepsy in Chinese Patients
-
CLINICAL_TRIALS study record update · 2021-06-15Study of Writing Improvement in Patients With Wilson Disease and Dystonia After One Session of Inhibitory Repetitive Transcranial Magnetic Stimulation
-
CLINICAL_TRIALS study record update · 2021-04-09Induced Pluripotent Stem Cells for the Development of Novel Drug Therapies for Hepatic and Neurological Wilson Disease
-
CLINICAL_TRIALS study record update · 2020-10-26Multi-Center Study for the Assessment of Copper Parameters in Wilson Disease Subjects on Standard of Care Treatment
-
CLINICAL_TRIALS study record update · 2018-09-06A Controlled Study of Potential Therapeutic Effect of Oral Zinc in Manifesting Carriers of Wilson Disease
-
CLINICAL_TRIALS study record update · 2018-07-18Clinical Efficacy of Artificial Liver Support System Using Combination of Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease - Related Liver Failure
-
CLINICAL_TRIALS study record update · 2017-08-23Multicentre, Retrospective and Prospective Study to Assess Long-Term Outcomes of Chelator-Based Treatment With Trientine in Wilson Disease Patients Withdrawn From Therapy With d-Penicillamine
-
CLINICAL_TRIALS study record update · 2014-05-19Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease
-
CLINICAL_TRIALS study record update · 2006-05-09ClinicalTrials.gov study NCT00004339